Numerous studies employed CXCR4 inhibitors to suppress the CXCL12/CXCR4 signals for treating cancer (Domanska et al., 2012; Biasci et al., 2020; Bockorny et al., 2020; Chaudary et al., 2021). The gene discussed is CXCR4; the disease is cancer.